ALTAMIRA THERAPEUTICS LTD
(NASDAQ: CYTO)
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
1.640
+0.020
(+1.23%)
Range
1.600 - 1.660
(3.75%)
Open
1.620
Previous Close
1.620
Bid Price
0.855
Bid Volume
18
Ask Price
0.890
Ask Volume
10
Volume
31,876
Value
-
Remark
Delayed prices. Updated at 04 May 2024 04:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
